From the human data, the urine of bladder cancer patients had significantly upregulated levels of CCL2, IL-6, CXCL10, IL-1b, IFN-g, TGF-b, and IL-8 in comparison to the healthy donors. The gene discussed is CCL2; the disease is urinary bladder carcinoma.